Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03112590
Title Phase I-II Study of Interferon-gamma in Patients With HER-2 Positive Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute

Her2-receptor positive breast cancer


Interferon gamma + Paclitaxel + Pertuzumab + Trastuzumab

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.